RBC Capital Reiterates Outperform on Insulet, Maintains $280 Price Target

Benzinga Newsdesk www.benzinga.com Negative 90.8%

Neg 90.8% Neu 0% Pos 0%

RBC Capital analyst Shagun Singh reiterates Insulet (NASDAQ:PODD) with a Outperform and maintains $280 price target.

Comments

No comments yet. Be the first!